BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 16, 2010
View Archived Issues
A Two-Step Procedure Leads To A One-For-All Flu Vaccine
Read More
Still No Partner; Somaxon Adds Sales Team for Silenor Launch
Read More
Evotec Acquiring DeveloGen for €16M Cash, Shares, Earnouts
Read More
Clinuvel's Former Tan Drug Succeeds in Porphyria Trial
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
FDA Panel Rejects Vivus Obesity Pill Qnexa
GAITHERSBURG, Md. – An FDA panel Thursday said the risks of fetal exposure, increased heart rate, depression and other problems outweighed the benefits of weight loss for Vivus Inc.'s Qnexa (phentermine/topiramate). (BioWorld Today)
Read More
Tissue-Bone Firm BioMimetic Raising $40M in Stock Offering
Read More